Skip to main content

Ryan Arthur F's Form 4 filing

Regeneron Pharmaceuticals, Inc. (REGN) · filed May 3, 2024

Accession no.
0001883850-24-000017
Filed
May 3, 2024
Trade date
May 1, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions. Open-market sales total $90.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Ryan Arthur FCIK 0001187443Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 1, 2024Common StockSSaleDisposed−3$889.50F2−$2,668.518,179Direct
May 1, 2024Common StockSSaleDisposed−2$890.75−$1,781.518,177Direct
May 1, 2024Common StockSSaleDisposed−7$891.52F3−$6,240.6418,170Direct
May 1, 2024Common StockSSaleDisposed−9$892.50F4−$8,032.518,161Direct
May 1, 2024Common StockSSaleDisposed−5$893.16F5−$4,465.818,156Direct
May 1, 2024Common StockSSaleDisposed−2$895.38F6−$1,790.7618,154Direct
May 1, 2024Common StockSSaleDisposed−3$896.59F7−$2,689.7718,151Direct
May 1, 2024Common StockSSaleDisposed−9$897.68F8−$8,079.1218,142Direct
May 1, 2024Common StockSSaleDisposed−17$898.51F9−$15,274.6718,125Direct
May 1, 2024Common StockSSaleDisposed−7$899.37F10−$6,295.5918,118Direct
May 1, 2024Common StockSSaleDisposed−5$900.45F11−$4,502.2518,113Direct
May 1, 2024Common StockSSaleDisposed−4$901.41F12−$3,605.6418,109Direct
May 1, 2024Common StockSSaleDisposed−1$902.66−$902.6618,108Direct
May 1, 2024Common StockSSaleDisposed−1$903.35−$903.3518,107Direct
May 1, 2024Common StockSSaleDisposed−1$904.80−$904.818,106Direct
May 1, 2024Common StockSSaleDisposed−2$905.50F13−$1,81118,104Direct
May 1, 2024Common StockSSaleDisposed−4$906.26F14−$3,625.0418,100Direct
May 1, 2024Common StockSSaleDisposed−2$907.54−$1,815.0818,098Direct
May 1, 2024Common StockSSaleDisposed−4$909.49F15−$3,637.9618,094Direct
May 1, 2024Common StockSSaleDisposed−6$910.47F16−$5,462.8218,088Direct
May 1, 2024Common StockSSaleDisposed−4$911.39F17−$3,645.5618,084Direct
May 1, 2024Common StockSSaleDisposed−1$912.29−$912.2918,083Direct
May 1, 2024Common StockSSaleDisposed−1$913.21−$913.2118,082Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents volume-weighted average price of sales of 3 shares of Company stock on May 1, 2024 at prices ranging from $889.41 to $889.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Represents volume-weighted average price of sales of 7 shares of Company stock on May 1, 2024 at prices ranging from $891.02 to $891.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Represents volume-weighted average price of sales of 9 shares of Company stock on May 1, 2024 at prices ranging from $892.01 to $892.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2024 at prices ranging from $893.05 to $893.54. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F6

Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2024 at prices ranging from $895.16 to $895.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F7

Represents volume-weighted average price of sales of 3 shares of Company stock on May 1, 2024 at prices ranging from $896.16 to $896.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F8

Represents volume-weighted average price of sales of 9 shares of Company stock on May 1, 2024 at prices ranging from $897.38 to $897.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F9

Represents volume-weighted average price of sales of 17 shares of Company stock on May 1, 2024 at prices ranging from $898.03 to $898.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F10

Represents volume-weighted average price of sales of 7 shares of Company stock on May 1, 2024 at prices ranging from $899.20 to $899.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F11

Represents volume-weighted average price of sales of 5 shares of Company stock on May 1, 2024 at prices ranging from $900.16 to $900.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F12

Represents volume-weighted average price of sales of 4 shares of Company stock on May 1, 2024 at prices ranging from $901.04 to $901.72. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F13

Represents volume-weighted average price of sales of 2 shares of Company stock on May 1, 2024 at prices ranging from $905.22 to $905.78. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F14

Represents volume-weighted average price of sales of 4 shares of Company stock on May 1, 2024 at prices ranging from $906.17 to $906.35. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F15

Represents volume-weighted average price of sales of 4 shares of Company stock on May 1, 2024 at prices ranging from $909.29 to $909.64. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F16

Represents volume-weighted average price of sales of 6 shares of Company stock on May 1, 2024 at prices ranging from $910.00 to $910.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

F17

Represents volume-weighted average price of sales of 4 shares of Company stock on May 1, 2024 at prices ranging from $911.03 to $911.73. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 1, 2024 at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)